NOTA DESTACADA DE CORREO FARMACUTICO: En la Argentina, la indicacin de semaglutida sigue siendo para personas adultas con diabetes tipo 2, que tienen obesidad y riesgo cardiovascular, explica la Dra
The unexpected shift towards phentermine, a lower-cost alternative at approximately $5 per month, emerges as a pragmatic response to the host of issues surrounding fulfillment of prescriptions for Wegovy including shortages, supply issues, the expiration of manufacturer coupons, and insurance coverage limitations which impact the accessibility of GLP-1 agonists
Similarly, affordable tirzepatide options including compounded formulations have expanded access for many patients
Furthermore, weight reduction has been associated with enhanced psychological well-being and adherence to treatment regimens, as patients who experience weight loss may be more motivated to adopt healthier lifestyles, including regular physical activity and improved dietary habits [86]
Sanyal et al., Nat Med, 2024) has examined endpoints relevant to obesity, type 2 diabetes, and metabolic dysfunction-associated steatotic liver disease (MASLD) under controlled clinical research protocols
Retatrutide in Canada: Access and What to Know For Canadians interested in Retatrutide, the current reality is that it is available as a research peptide rather than a prescription medication
